Not checkedNot checked for notices yet.
The Effectiveness of Nonsteroidal Anti-Inflammatory Drugs in Patients with Neurocompressive Pain Syndrome of Lumbosacral Spine in Degenerative Dystrophic Diseases
Ya.V. Fischenko
Bolʹ, Sustavy, Pozvonočnik · 2015
doi:10.22141/2224-1507.3.19.2015.79269 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
This article provides a retrospective analysis of medical records of 38 patients (28 women and 10 men) aged 54.7 ± 2.2 (27 to 86) years, who underwent conservative hospital treatment with a diagnosis of osteochondrosis, protrusion or herniated disc, lumbar spinal stenosis. Personal data (according to Roland-Morris (RM) scale, visual analogue scale (VAS)), Oswestry Disability Index (ODI) and the index of recovery; X-ray data and neurological examination findings were statistically assessed before and after the treatment. As a result, the positive dynamics of the quality of life indicator according to Roland-Morris questionnaire and Oswestry Disability Index has been noted both immediately after the treatment (RM = 27.1 %, ODI = 30.5 %), and in 6 months (PM = 32.7 %, ODI = 35.2 %). The high effectiveness of nonsteroidal anti-inflammatory drugs and muscle relaxants has been observed in the treatment of neurocompressive pain syndrome in patients according to VAS (89.5 % of patients noted regression of pain syndrome immediately after the treatment, in 86.8 % of patients the outcome was positive for 6 months). Univariate analysis of variance showed that the presence of scoliosis, spondylolisthesis, L4-L5 instability and deforming arthrosis of the hip joints in patients are negative prognostic signs of the treatment efficiency.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.